Effect of functionalized magnetic MnFe2O4 nanoparticles on fibrillation of human serum albumin

Journal of Physical Chemistry B

Volumn 118, Issue 40, 2014, Pages 11667-11676

  Sen, Shubhatam ^a   Konar, Suraj ^a   Pathak, Amita ^a   Dasgupta, Swagata ^a   Dasgupta, Sunando ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FUNCTIONALIZED; HUMAN SERUM ALBUMINS;

AMYLOID; FERRIC ION; MAGNETITE NANOPARTICLE; MANGANESE DERIVATIVE; MANGANESE FERRITE; SERUM ALBUMIN;

AMINATION; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; HUMAN; PROTEIN CONFORMATION; ULTRASTRUCTURE;

AMINATION; AMYLOID; FERRIC COMPOUNDS; HUMANS; MAGNETITE NANOPARTICLES; MANGANESE COMPOUNDS; MODELS, MOLECULAR; PROTEIN CONFORMATION; SERUM ALBUMIN;

EID: 84907938199     PISSN: 15206106     EISSN: 15205207     Source Type: Journal    
DOI: 10.1021/jp507902y     Document Type: Article

References (67)

1. Chiti, F.; Dobson, C. M. Protein Misfolding, Functional Amyloid, and Human Disease Annu. Rev. Biochem. 2006, 75, 333-366
2. Sipe, J. D.; Benson, M. D.; Buxbaum, J. N.; Ikeda, S.; Merlini, G.; Saraiva, M. J. M.; Westermark, P. Amyloid Fibril Protein Nomenclature: 2010 Recommendations from the Nomenclature Committee of the International Society of Amyloidosis Amyloid 2010, 17 (3-4) 101-104
3. Selkoe, D. J. Folding Proteins in Fatal Ways Nature 2003, 426 (6968) 900-904
4. Kagan, B. L.; Thundimadathil, J. Amyloid Peptide Pores and the Beta Sheet Conformation Adv. Exp. Med. Biol. 2010, 677, 150-167
5. Roberson, E. D.; Scearce-Levie, K.; Palop, J. J.; Yan, F. R.; Cheng, I. H.; Wu, T.; Gerstein, H.; Yu, G. Q.; Mucke, L. Reducing Endogenous Tau Ameliorates Amyloid Beta-Induced Deficits in an Alzheimers Disease Mouse Model Science 2007, 316 (5825) 750-754
6. Taboada, P.; Barbosa, S.; Castro, E.; Mosquera, V. Amyloid Fibril Formation and Other Aggregate Species Formed by Human Serum Albumin Association J. Phys. Chem. B 2006, 110 (42) 20733-20736
7. Juarez, J.; Taboada, P.; Mosquera, V. Existence of Different Structural Intermediates on the Fibrillation Pathway of Human Serum Albumin Biophys. J. 2009, 96 (6) 2353-2370
8. He, X. M.; Carter, D. C. Atomic-Structure and Chemistry of Human Serum-Albumin Nature 1992, 358 (6383) 209-215
9. Carter, D. C.; Ho, J. X. Structure of Serum-Albumin Adv. Protein Chem. 1994, 45, 153-203
10. Gorinstein, S.; Caspi, A.; Rosen, A.; Goshev, I.; Zemser, M.; Weisz, M.; Anon, M. C.; Libman, I.; Lerner, H. T.; Trakhtenberg, S. Structure Characterization of Human Serum Proteins in Solution and Dry State J. Pept. Res. 2002, 59 (2) 71-78
11. Juarez, J.; Lopez, S. G.; Cambon, A.; Taboada, P.; Mosquera, V. Influence of Electrostatic Interactions on the Fibrillation Process of Human Serum Albumin J. Phys. Chem. B 2009, 113 (30) 10521-10529
12. Juarez, J.; Taboada, P.; Goy-Lopez, S.; Cambon, A.; Madec, M. B.; Yeates, S. G.; Mosquera, V. Additional Supra-Self-Assembly of Human Serum Albumin under Amyloid-Like-Forming Solution Conditions J. Phys. Chem. B 2009, 113 (36) 12391-12399
13. Taboada, P.; Barbosa, S.; Castro, E.; Gutierrez-Pichel, M.; Mosquera, V. Effect of Solvation on the Structure Conformation of Human Serum Albumin in Aqueous-Alcohol Mixed Solvents Chem. Phys. 2007, 340 (1-3) 59-68
14. Pandey, N. K.; Ghosh, S.; Dasgupta, S. Effect of Surfactants on Preformed Fibrils of Human Serum Albumin Int. J. Biol. Macromol. 2013, 59, 39-45
15. Stirpe, A.; Pantusa, M.; Rizzuti, B.; Sportelli, L.; Bartucci, R.; Guzzi, R. Early Stage Aggregation of Human Serum Albumin in the Presence of Metal Ions Int. J. Biol. Macromol. 2011, 49 (3) 337-342
16. Pandey, N. K.; Ghosh, S.; Dasgupta, S. Fructose Restrains Fibrillogenesis in Human Serum Albumin Int. J. Biol. Macromol. 2013, 61, 424-432
17. Pandey, N. K.; Ghosh, S.; Nagy, N. V.; Dasgupta, S. Fibrillation of Human Serum Albumin Shows Nonspecific Coordination on Stoichiometric Increment of Copper(II) J. Biomol. Struct. Dyn. 2013, 32, 1366-1378
18. Kogan, M. J.; Olmedo, I.; Hosta, L.; Guerrero, A. R.; Cruz, L. J.; Albericio, F. Peptides and Metallic Nanoparticles for Biomedical Applications Nanomedicine 2007, 2 (3) 287-306
19. Stark, W. J. Nanoparticles in Biological Systems Angew. Chem., Int. Ed. 2011, 50 (6) 1242-1258
20. Koziara, J. M.; Lockman, P. R.; Allen, D. D.; Mumper, R. J. In Situ Blood-Brain Barrier Transport of Nanoparticles Pharm. Res. 2003, 20 (11) 1772-1778
21. Linse, S.; Cabaleiro-Lago, C.; Xue, W. F.; Lynch, I.; Lindman, S.; Thulin, E.; Radford, S. E.; Dawson, K. A. Nucleation of Protein Fibrillation by Nanoparticles Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (21) 8691-8696
22. Zhang, D. M.; Neumann, O.; Wang, H.; Yuwono, V. M.; Barhoumi, A.; Perham, M.; Hartgerink, J. D.; Wittung-Stafshede, P.; Halas, N. J. Gold Nanoparticles Can Induce the Formation of Protein-Based Aggregates at Physiological pH Nano Lett. 2009, 9 (2) 666-671
23. Triulzi, R. C.; Dai, Q.; Zou, J. H.; Leblanc, R. M.; Gu, Q.; Orbulescu, J.; Huo, Q. Photothermal Ablation of Amyloid Aggregates by Gold Nanoparticles Colloids Surf., B 2008, 63 (2) 200-208
24. Rocha, S.; Thuneman, A. F.; Pereira, M. D.; Coelho, M.; Mohwald, H.; Brezesinski, G. Influence of Fluorinated and Hydrogenated Nanoparticles on the Structure and Fibrillogenesis of Amyloid Beta-Peptide Biophys. Chem. 2008, 137 (1) 35-42
25. Vannoy, C. H.; Leblanc, R. M. Effects of DHLA-Capped CdSe/ZnS Quantum Dots on the Fibrillation of Human Serum Albumin J. Phys. Chem. B 2010, 114 (33) 10881-10888
26. Goy-Lopez, S.; Juarez, J.; Alatorre-Meda, M.; Casals, E.; Puntes, V. F.; Taboada, P.; Mosquera, V. Physicochemical Characteristics of Protein-NP Bioconjugates: The Role of Particle Curvature and Solution Conditions on Human Serum Albumin Conformation and Fibrillogenesis Inhibition Langmuir 2012, 28 (24) 9113-9126
27. de Vries, I. J. M.; Lesterhuis, W. J.; Barentsz, J. O.; Verdijk, P.; van Krieken, J. H.; Boerman, O. C.; Oyen, W. J. G.; Bonenkamp, J. J.; Boezeman, J. B.; Adema, G. J.; Bulte, J. W. M.; Scheenen, T. W. J.; Punt, C. J. A.; Heerschap, A.; Figdor, C. G. Magnetic Resonance Tracking of Dendritic Cells in Melanoma Patients for Monitoring of Cellular Therapy Nat. Biotechnol. 2005, 23 (11) 1407-1413
28. Zhang, Y.; Kohler, N.; Zhang, M. Q. Surface Modification of Superparamagnetic Magnetite Nanoparticles and Their Intracellular Uptake Biomaterials 2002, 23 (7) 1553-1561
29. Neuberger, T.; Schopf, B.; Hofmann, H.; Hofmann, M.; von Rechenberg, B. Superparamagnetic Nanoparticles for Biomedical Applications: Possibilities and Limitations of a New Drug Delivery System J. Magn. Magn. Mater. 2005, 293 (1) 483-496
30. Ito, A.; Shinkai, M.; Honda, H.; Kobayashi, T. Medical Application of Functionalized Magnetic Nanoparticles J. Biosci. Bioeng. 2005, 100 (1) 1-11
31. Pengo, P.; Baltzer, L.; Pasquato, L.; Scrimin, P. Substrate Modulation of the Activity of an Artificial Nanoesterase Made of Peptide-Functionalized Gold Nanoparticles Angew. Chem., Int. Ed. 2007, 46 (3) 400-404
32. Hergt, R.; Hiergeist, R.; Hilger, I.; Kaiser, W. A.; Lapatnikov, Y.; Margel, S.; Richter, U. Maghemite Nanoparticles with Very High AC-Losses for Application in RF-Magnetic Hyperthermia J. Magn. Magn. Mater. 2004, 270 (3) 345-357
33. Skaat, H.; Margel, S. Synthesis of Fluorescent-Maghemite Nanoparticles as Multimodal Imaging Agents for Amyloid-Beta Fibrils Detection and Removal by a Magnetic Field Biochem. Biophys. Res. Commun. 2009, 386 (4) 645-649
34. Skaat, H.; Belfort, G.; Margel, S. Synthesis and Characterization of Fluorinated Magnetic Core-Shell Nanoparticles for Inhibition of Insulin Amyloid Fibril Formation. Nanotechnology 2009, 20 (22).
35. Skaat, H.; Shafir, G.; Margel, S. Acceleration and Inhibition of Amyloid-Beta Fibril Formation by Peptide-Conjugated Fluorescent-Maghemite Nanoparticles J. Nanopart. Res. 2011, 13 (8) 3521-3534
36. 4 Magnetic Nanoparticles on Lysozyme Amyloid Aggregation Nanotechnology 2010, 21 (6 065103
37. Siposova, K.; Kubovcikova, M.; Bednarikova, Z.; Koneracka, M.; Zavisova, V.; Antosova, A.; Kopcansky, P.; Daxnerova, Z.; Gazova, Z. Depolymerization of Insulin Amyloid Fibrils by Albumin-Modified Magnetic Fluid Nanotechnology 2012, 23 (5 055101
38. Grancharov, S. G.; Zeng, H.; Sun, S. H.; Wang, S. X.; OBrien, S.; Murray, C. B.; Kirtley, J. R.; Held, G. A. Bio-functionalization of Monodisperse Magnetic Nanoparticles and Their Use as Biomolecular Labels in a Magnetic Tunnel Junction Based Sensor J. Phys. Chem. B 2005, 109 (26) 13030-13035
39. 4) Nanoparticles Langmuir 2005, 21 (24) 11173-11179
40. Ebrahiminezhad, A.; Ghasemi, Y.; Rasoul-Amini, S.; Barar, J.; Davaran, S. Preparation of Novel Magnetic Fluorescent Nanoparticles Using Amino Acids Colloids Surf., B 2013, 102, 534-539
41. Sahu, S. K.; Chakrabarty, A.; Bhattacharya, D.; Ghosh, S. K.; Pramanik, P. Single Step Surface Modification of Highly Stable Magnetic Nanoparticles for Purification of His-tag Proteins J. Nanopart. Res. 2011, 13 (6) 2475-2484
42. Kovalenko, A.; Jouhannaud, J.; Polavarapu, P.; Krafft, M. P.; Waton, G.; Pourroy, G. Hollow Magnetic Microspheres Obtained by Nanoparticle Adsorption on Surfactant Stabilized Microbubbles Soft Matter 2014, 10 (28) 5147-5156
43. Pace, C. N.; Vajdos, F.; Fee, L.; Grimsley, G.; Gray, T. How to Measure and Predict the Molar Absorption-Coefficient of a Protein Protein Sci. 1995, 4 (11) 2411-2423
44. Whitmore, L.; Wallace, B. A. Dichroweb, an Online Server for Protein Secondary Structure Analyses from Circular Dichroism Spectroscopic Data Nucleic Acids Res. 2004, 32, W668-W673
45. Greenfield, N. J. Using Circular Dichroism Collected as a Function of Temperature to Determine the Thermodynamics of Protein Unfolding and Binding Interactions Nat. Protoc. 2006, 1 (6) 2527-2535
46. 4 Nanoparticles to Impart Intrinsic Multiple Fluorescence and Novel Photocatalytic Properties ACS Appl. Mater. Interfaces 2014, 6 (7) 4903-4910
47. 4 Synthesized by a Thermal Treatment Method ISRN Nanotechnol. 2012, 2012, 11
48. z (z = 0.0, 0.10, 0.15, 0.25). J. Appl. Phys. 2010, 108 (9).
49. 4 Nanoparticles Mater. Chem. Phys. 2010, 124 (2-3) 964-969
50. Can, K.; Ozmen, M.; Ersoz, M. Immobilization of Albumin on Aminosilane Modified Superparamagnetic Magnetite Nanoparticles and its Characterization Colloids Surf., B 2009, 71 (1) 154-159
51. Yamaura, M.; Camilo, R. L.; Sampaio, L. C.; Macedo, M. A.; Nakamura, M.; Toma, H. E. Preparation and Characterization of (3-Aminopropyl) Triethoxysilane-Coated Magnetite Nanoparticles J. Magn. Magn. Mater. 2004, 279 (2-3) 210-217
52. Wang, Z. J.; Zhu, H.; Wang, X. L.; Yang, F.; Yang, X. R. One-Pot Green Synthesis of Biocompatible Arginine-Stabilized Magnetic Nanoparticles Nanotechnology 2009, 20 (46 465606
53. 4@PPy Nanoparticles by a Novel One-Pot Route. Nanoscale Res. Lett. 2011, 6.
54. Levine, H. Thioflavine-T Interaction with Synthetic Alzheimers-Disease Beta-Amyloid Peptides-Detection of Amyloid Aggregation in Solution Protein Sci. 1993, 2 (3) 404-410
55. LeVine, H. Quantification of Beta-Sheet Amyloid Fibril Structures with Thioflavin T Methods Enzymol. 1999, 309, 274-284
56. Sen, P.; Fatima, S.; Ahmad, B.; Khan, R. H. Interactions of Thioflavin T with Serum Albumins: Spectroscopic Analyses Spectrochim. Acta Mol. Biomol. Spectros. 2009, 74 (1) 94-99
57. Klunk, W. E.; Pettegrew, J. W.; Abraham, D. J. Quantitative-Evaluation of Congo Red Binding to Amyloid-Like Proteins with a Beta-Pleated Sheet Conformation J. Histochem. Cytochem. 1989, 37 (8) 1273-1281
58. Kirkitadze, M. D.; Condron, M. M.; Teplow, D. B. Identification and Characterization of Key Kinetic Intermediates in Amyloid Beta-Protein Fibrillogenesis J. Mol. Biol. 2001, 312 (5) 1103-1119
59. Dockal, M.; Carter, D. C.; Ruker, F. Conformational Transitions of the Three Recombinant Domains of Human Serum Albumin Depending on pH J. Biol. Chem. 2000, 275 (5) 3042-3050
60. Yu, C. H.; Al-Saadi, A.; Shih, S. J.; Qiu, L.; Tam, K. Y.; Tsang, S. C. Immobilization of BSA on Silica-Coated Magnetic Iron Oxide Nanoparticle J. Phys. Chem. C 2009, 113 (2) 537-543
61. Finder, V. H.; Glockshuber, R. Amyloid-Beta Aggregation Neurodegener. Dis. 2007, 4 (1) 13-27
62. (20-29) Fibrillation by Polymeric Nanoparticles Langmuir 2010, 26 (5) 3453-3461
63. Cabaleiro-Lago, C.; Quinlan-Pluck, F.; Lynch, I.; Lindman, S.; Minogue, A. M.; Thulin, E.; Walsh, D. M.; Dawson, K. A.; Linse, S. Inhibition of Amyloid Beta Protein Fibrillation by Polymeric Nanoparticles J. Am. Chem. Soc. 2008, 130 (46) 15437-15443
64. Sugio, S.; Kashima, A.; Mochizuki, S.; Noda, M.; Kobayashi, K. Crystal Structure of Human Serum Albumin at 2.5 Å Resolution Protein Eng. 1999, 12 (6) 439-446
65. Sun, L.; Huang, C.; Gong, T.; Zhou, S. B. A Biocompatible Approach to Surface Modification: Biodegradable Polymer Functionalized Super-Paramagnetic Iron Oxide Nanoparticles Mater. Sci. Eng., C 2010, 30 (4) 583-589
66. 6 Nanoparticles for Adsorption of Bovine Serum Albumin Applications Nanoscale Res. Lett. 2013, 8, 207
67. Wiig, H.; Tenstad, O.; Bert, J. L. Effect of Hydration on Interstitial Distribution of Charged Albumin in Rat Dermis in Vitro J. Physiol. 2005, 569 (2) 631-641